These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14643414)

  • 1. Beryllium: genotoxicity and carcinogenicity.
    Gordon T; Bowser D
    Mutat Res; 2003 Dec; 533(1-2):99-105. PubMed ID: 14643414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity, carcinogenicity and teratogenicity of beryllium.
    Léonard A; Lauwerys R
    Mutat Res; 1987 Jul; 186(1):35-42. PubMed ID: 3600684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium metal II. a review of the available toxicity data.
    Strupp C
    Ann Occup Hyg; 2011 Jan; 55(1):43-56. PubMed ID: 21196456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity of beryllium hydroxide and alloys.
    Groth DH; Kommineni C; Mackay GR
    Environ Res; 1980 Feb; 21(1):63-84. PubMed ID: 7389706
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical significance of beryllium.
    Aller AJ
    J Trace Elem Electrolytes Health Dis; 1990 Mar; 4(1):1-6. PubMed ID: 2135953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the genotoxicity of beryllium sulphate in vitro and in vivo.
    Ashby J; Ishidate M; Stoner GD; Morgan MA; Ratpan F; Callander RD
    Mutat Res; 1990 Mar; 240(3):217-25. PubMed ID: 2179717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of lung cancer associated with quantitative beryllium exposure metrics within an occupational cohort.
    Schubauer-Berigan MK; Deddens JA; Couch JR; Petersen MR
    Occup Environ Med; 2011 May; 68(5):354-60. PubMed ID: 21084327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carcinogenicity of beryllium.
    Kuschner M
    Environ Health Perspect; 1981 Aug; 40():101-5. PubMed ID: 7023926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
    McGregor D
    Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium metal I. experimental results on acute oral toxicity, local skin and eye effects, and genotoxicity.
    Strupp C
    Ann Occup Hyg; 2011 Jan; 55(1):30-42. PubMed ID: 21196457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity of o-aminoazotoluene (AAT) determined by the Ames test, the in vitro chromosomal aberration test, and the transgenic mouse gene mutation assay.
    Ohsawa K; Hirano N; Sugiura M; Nakagawa S; Kimura M
    Mutat Res; 2000 Nov; 471(1-2):113-26. PubMed ID: 11080667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenic responses of transgenic heterozygous p53 knockout mice to inhaled 239PuO2 or metallic beryllium.
    Finch GL; March TH; Hahn FF; Barr EB; Belinsky SA; Hoover MD; Lechner JF; Nikula KJ; Hobbs CH
    Toxicol Pathol; 1998; 26(4):484-91. PubMed ID: 9715507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.
    Stefaniak AB; Chipera SJ; Day GA; Sabey P; Dickerson RM; Sbarra DC; Duling MG; Lawrence RB; Stanton ML; Scripsick RC
    J Toxicol Environ Health A; 2008; 71(22):1468-81. PubMed ID: 18836922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beryllium: laboratory evidence.
    Flamm WG
    IARC Sci Publ; 1985; (65):199-201. PubMed ID: 3866748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity, carcinogenicity, and teratogenicity of acrylonitrile.
    Léonard A; Gerber GB; Stecca C; Rueff J; Borba H; Farmer PB; Sram RJ; Czeizel AE; Kalina I
    Mutat Res; 1999 May; 436(3):263-83. PubMed ID: 10354525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beryllium and lung cancer: a weight of evidence evaluation of the toxicological and epidemiological literature.
    Hollins DM; McKinley MA; Williams C; Wiman A; Fillos D; Chapman PS; Madl AK
    Crit Rev Toxicol; 2009; 39 Suppl 1():1-32. PubMed ID: 19384680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium contamination and exposure monitoring in an inhalation laboratory setting.
    Muller C; Audusseau S; Salehi F; Truchon G; Chevalier G; Mazer B; Kennedy G; Zayed J
    Toxicol Ind Health; 2010 Feb; 26(1):39-45. PubMed ID: 20056744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutagenesis; 2012 Jul; 27(4):387-413. PubMed ID: 22228823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.